The model employs evidence-based prescribing of FDA-approved GLP-1 and GIP agonists when clinically appropriate, pairs medication with lifestyle guidance, and prioritizes ongoing dose titration and adverse-effect monitoring
Code availability The specific packages and versions used for analyzing RNA sequencing and data processing, including DESeq2 (version 1.40.2) and clusterProfiler (version 4.8.3), are explicitly stated in Methods
Suitable for All Skin Types: The mild, skin-friendly composition ensures effective cleansing without harshness, making it suitable even for sensitive skin
2013 Aug 1 [cited 2024 Mar 2];183205
doi: 10.1038/nrgastro.2015.150 11 SampsonTRDebeliusJWThronTJanssenSShastriGGIlhanZEet al
Low IGF-1 may suggest: Growth hormone deficiency Chronic inflammation or illness Poor nutrition or malabsorption Low protein intake Chronic stress or elevated cortisol Liver disease High IGF-1 may suggest: Excess growth hormone (acromegaly) High protein/calorie intake Insulin resistance or high insulin levels Certain cancers or tumor risk (if sustained at high levels) Use of growth hormone therapy or certain peptides Optimal IGF-1 Levels While labs provide wide reference ranges, optimal levels are more specific when considering health, longevity, and performance goals
